Sherwin-Williams SEC Filings

Sherwin-Williams President & CEO Heidi G. Petz reported a tax-related share disposition tied to equity compensation. On February 13, 2026, 3,322 shares of Common Stock were disposed of at $372.49 per share through a tax-withholding disposition, where shares were mandatorily withheld by the company to cover taxes upon vesting of 8,350 restricted stock units granted in 2023.

After this transaction, Petz directly beneficially owned 17,162 shares of Common Stock, and indirectly held 376.78 shares through participation in The Sherwin-Williams Company 401(k) Plan as of the trustee’s February 13, 2026 statement.

The Sherwin-Williams Company entered into Amendment No. 1 to its Amended and Restated Credit Agreement with Citicorp USA, Inc. and a syndicate of lenders. The amendment’s primary purpose is to extend the maturity of $75,000,000 in borrowing and letter-of-credit commitments from June 20, 2026 to December 20, 2030.

The lenders and their affiliates have provided Sherwin-Williams and its subsidiaries with various banking and financial services in the past and may continue to do so for customary fees. The full text of Amendment No. 1 is filed as an exhibit and incorporated by reference.

Sherwin-Williams executive Davie Colin M., President & GM, Global Supply Chain, reported stock transactions dated February 2, 2026. He exercised an employee stock option for 2,976 shares of common stock at an exercise price of $127.98 per share, then sold 2,976 shares of common stock at a weighted average price of $359.50 per share. Following these trades, he directly owned 5,365 shares of Sherwin-Williams common stock and held an additional 559.64 shares indirectly through The Sherwin-Williams Company 401(k) Plan as of the plan’s December 31, 2025 statement. The option position reported was reduced to zero after the exercise.

An insider associated with SHW filed a notice of proposed sale of 2,976 shares of common stock. The planned sale, to be executed through Fidelity Brokerage Services LLC on the NYSE around 02/02/2026, has an stated aggregate market value of $1,070,033.70.

The shares relate to an option granted on 10/18/2017 and acquired on 02/02/2026 for cash. The filing notes that 247,893,513 shares of this class of common stock are outstanding and includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer.

The Vanguard Group filed an amended ownership report showing a significant stake in The Sherwin-Williams Company. Vanguard reports beneficial ownership of 23,237,722 shares of Sherwin-Williams common stock, representing 9.37% of the outstanding class.

Vanguard reports shared voting power over 2,278,267 shares and shared dispositive power over 23,237,722 shares, with no sole voting or dispositive power. The filing notes that, following an internal realignment on January 12, 2026, certain Vanguard subsidiaries or business divisions are expected to report beneficial ownership separately while pursuing the same investment strategies as before.

The Sherwin-Williams Company filed a current report to furnish its latest financial update. On January 29, 2026, the company issued a press release announcing its financial results for the fourth quarter and full year ended December 31, 2025, along with certain additional information. The press release is included as Exhibit 99.1 and is incorporated by reference, but is treated as “furnished” rather than “filed,” which limits potential liability and controls how the information may be used in other securities filings.

The Sherwin-Williams Company director Thomas Williams reported an automatic equity award under a director fee plan. On 01/09/2026 he acquired 97.66 deferred stock units tied to Sherwin-Williams common stock through the 2005 Director Deferred Fee Plan, using a weighted average share price of $345.60 to calculate the units. Each deferred stock unit is economically equal to one share of common stock and will be paid in stock, generally after he leaves the board. After this transaction, he held a total of 1,053.14 deferred stock units indirectly under the Deferred Fee Plan, and 1,813 directly held equity interests made up of 1,147 restricted stock units and 666 shares of common stock.

Sherwin-Williams director Michael H. Thaman reported an automatic grant of deferred stock units under the company’s 2005 Director Deferred Fee Plan. On January 9, 2026, he acquired 97.66 deferred stock units linked to Sherwin-Williams common stock at a weighted average share price of $345.6, in an exempt transaction under this plan. After this credit, he held 5,480.97 deferred stock units indirectly in the Deferred Fee Plan, which will generally be paid out in stock after he leaves the board. He also reported 7,553 securities held directly, consisting of 1,150 restricted stock units and 6,403 shares of common stock, where each RSU represents the right to receive one share.

The Sherwin-Williams Company director Robert James Gamgort reported acquiring additional deferred stock units linked to the company’s common stock. On 01/09/2026, he received 97.66 deferred stock units in an exempt transaction under the 2005 Director Deferred Fee Plan, based on a weighted average share price of $345.6. Each deferred stock unit is economically equivalent to one share and is payable in stock, generally after his service as a director ends.

Following this transaction, Gamgort held 380.04 deferred stock units under the Deferred Fee Plan on an indirect basis and separately held 517 restricted stock units directly, each RSU representing the right to receive one share of common stock.